LOUISE BAUR
Louise Baur is Chair of Child and Adolescent Health at The University of Sydney and is also a National Health and Medical Research Council (NHMRC) Leadership Fellow. She is a consultant paediatrician in Weight Management Services at Sydney Children’s Hospitals Network where her team provides multi-disciplinary care for children and adolescents with moderate to severe obesity.
Louise has specific research expertise in the prevention and management of children and adolescent obesity. For example, she is Director of the Australian NHMRC Centre of Research Excellence in the Early Prevention of Obesity in Childhood (www.earlychildhoodobesity.com), the principal investigator of the Fast Track Trial, and an investigator on the Eating Disorders In weight-related Therapy (EDIT) Collaboration (www.editcollaboration.com)
Louise is also President of the World Obesity Federation and President of the Australian Academy of Health and Medical Sciences, Australia’s newest Learned Academy.
Louise has specific research expertise in the prevention and management of children and adolescent obesity. For example, she is Director of the Australian NHMRC Centre of Research Excellence in the Early Prevention of Obesity in Childhood (www.earlychildhoodobesity.com), the principal investigator of the Fast Track Trial, and an investigator on the Eating Disorders In weight-related Therapy (EDIT) Collaboration (www.editcollaboration.com)
Louise is also President of the World Obesity Federation and President of the Australian Academy of Health and Medical Sciences, Australia’s newest Learned Academy.
Check the activity agenda
Wednesday, June 26, 2024
• Room 3+4 - Bernard Jeanrenaud
14:15-15:45
SESSION: THE GOLDEN AGE IN OBESITY PHARMACOTHERAPY
Bridging the gap between clinical and surgical treatments: what have we reached so far?
Future poli-agonists for the treatment of obesity and metabolic diseases
“Novel targets – appetite and beyond – Are we getting there?
Discussion
Coordinator: Louise Baur (Australia)
Bridging the gap between clinical and surgical treatments: what have we reached so far?
Speaker: Walmir Coutinho (RJ)
Future poli-agonists for the treatment of obesity and metabolic diseases
Speaker: Carel Le Roux (Ireland)
“Novel targets – appetite and beyond – Are we getting there?
Speaker: Donna Ryan (United States)
Discussion
Thursday, June 27, 2024
• Room 1 - Alfredo Halpern
08:00-09:30
SESSION: THE LANCET COMMISSION ON THE DEFINITION OF CLINICAL OBESITY: BACKGROUND, OBJECTIVES AND PROGRESS REPORT
Background to the Lancet Commission
The pathophysiology of obesity as a discrete disease
BMI as a clinical and epidemiological instrument
BMI and obesity considerations in paediatric populations
Discussion
Coordinator: Eric Ravussin (United States)
Background to the Lancet Commission
Speaker: Ricardo Vitor Cohen (SP)
The pathophysiology of obesity as a discrete disease
Speaker: Carel Le Roux (Ireland)
BMI as a clinical and epidemiological instrument
Speaker: Ricardo Vitor Cohen (SP)
BMI and obesity considerations in paediatric populations
Speaker: Louise Baur (Australia)
Discussion
• Room 2 - John Waterlow
11:00-12:30
SYMPOSIUM: ADDRESSING OBESITY DURING THE LIFE COURSE - PART 1
Treating obesity before and during pregnancy – is it possible to reduce obesity risk in the offspring?
Interventions in early childhood to prevent obesity
Managing obesity in adolescents: balancing metabolic benefits and potential psychological harms
Discussion
Coordinator: Livia Lugarinho Correa de Mello (RJ)
Treating obesity before and during pregnancy – is it possible to reduce obesity risk in the offspring?
Speaker: Bianca de Almeida Pititto (SP)
Interventions in early childhood to prevent obesity
Speaker: Louise Baur (Australia)
Managing obesity in adolescents: balancing metabolic benefits and potential psychological harms
Speaker: Louise Baur (Australia)
Discussion
Friday, June 28, 2024
• Room 4 - Peter Kopelman
16:30-18:00
IDF/WOF JOINT SYMPOSIUM: INTERNATIONAL DIABETES FEDERATION POSITION STATEMENT FOR THE DIAGNOSIS OF INTERMEDIATE HYPERGLYCEMIA AND TYPE 2 DIABETES
Introduction remarks - WOF and IDF Chairs
The IDF new Position Statement: novel criteria for the diagnosis of Diabetes
Rationale for the IDF Task Force recommendations for the diagnosis of IH and Type 2 diabetes
Implications of the recommendation for the prevention and management of obesity/diabetes and its complications
Discussion
Coordinator: Louise Baur (Australia)
Coordinator: Hermelinda Pedrosa (DF)
Introduction remarks - WOF and IDF Chairs
The IDF new Position Statement: novel criteria for the diagnosis of Diabetes
Speaker: Akthar Hussain (Norway)
Rationale for the IDF Task Force recommendations for the diagnosis of IH and Type 2 diabetes
Speaker: Maria Ines Schmidt (RS)
Implications of the recommendation for the prevention and management of obesity/diabetes and its complications
Speaker: Maria Edna de Melo (SP)
Discussion
Saturday, June 29, 2024
• Room 1 - Alfredo Halpern
14:00-15:30
SESSION: ADOLESCENT HEALTH
Abstracts - 129804: ASSOCIATION OF METABOLIC HEALTH AND METABOLIC UNHEALTH OBESITY WITH HYPERGLYCEMIC CLAMP PARAMETERS IN ADOLESCENTS – BRAMS (BRAZILIAN METABOLIC SYNDROME STUDY) - Presenter: Abstracts - 129804: ASSOCIATION OF METABOLIC HEALTH AND METABOLIC UNHEALTH OBESITY WITH HYPERGLYCEMIC CLAMP PARAMETERS IN ADOLESCENTS – BRAMS (BRAZILIAN METABOLIC SYNDROME STUDY) - Time: 8 min. Presenter: Maria Eduarda Martelli
Current and Future Pharmacotherapies for Obesity in Children and Adolescents
Insulin resistance in puberty: physiology or pathology?
Bariatric Surgery in Adolescents with obesity
Discussion
Coordinator: Louise Cominato (SP)
Abstracts - 129804: ASSOCIATION OF METABOLIC HEALTH AND METABOLIC UNHEALTH OBESITY WITH HYPERGLYCEMIC CLAMP PARAMETERS IN ADOLESCENTS – BRAMS (BRAZILIAN METABOLIC SYNDROME STUDY) - Presenter: Abstracts - 129804: ASSOCIATION OF METABOLIC HEALTH AND METABOLIC UNHEALTH OBESITY WITH HYPERGLYCEMIC CLAMP PARAMETERS IN ADOLESCENTS – BRAMS (BRAZILIAN METABOLIC SYNDROME STUDY) - Time: 8 min. Presenter: Maria Eduarda Martelli
Current and Future Pharmacotherapies for Obesity in Children and Adolescents
Speaker: Louise Baur (Australia)
Insulin resistance in puberty: physiology or pathology?
Speaker: Daniel Minutti de Oliveira (SP)
Bariatric Surgery in Adolescents with obesity
Speaker: Durval Damiani (SP)
Discussion
• Room 5 - Phillip James
11:00-12:30
SESSION: CHILDHOOD OBESITY INTERVENTIONS
Marketing directed at children
The new obesity prevention strategy in Brazil and the school environment
Health systems interventions
Discussion
Coordinator: Magdalena Wetzel (Argentina)
Marketing directed at children
Speaker: Rafael Claro (MG)
The new obesity prevention strategy in Brazil and the school environment
Speaker: Gisele Bortolini (DF)
Speaker: Stephanie Amaral (DF)
Health systems interventions
Speaker: Louise Baur (Australia)
Discussion
Venue
Centro de Convenções Frei Caneca
R. Frei Caneca, 569 - Bela Vista,
São Paulo - SP, 01307-001
R. Frei Caneca, 569 - Bela Vista,
São Paulo - SP, 01307-001
website ACCOMMODATION
PROMOTED BY
MANAGEMENT
Tourism Agency
DIAMOND SPONSOR
GOLD SPONSOR
BRONZE SPONSOR
SPONSOR
